Key Points
CRH signed a definitive agreement on June 22, 2026, to acquire Arcosa for $8.5 billion.
The offer price is $150 per share, a 25% premium to Arcosa's 60-day VWAP as of June 18.
The deal values Arcosa at 11.5x 2026E Adjusted EBITDA, including $175 million in run-rate synergies.
CRH expects the transaction to be earnings and cash flow accretive within the first 12 months.
CRH made its biggest-ever acquisition official on June 22, 2026, signing a definitive agreement to acquire Arcosa, Inc. (NYSE: ACA) in an all-cash transaction. CRH will pay $150 per share in cash, with the transaction valuing Arcosa at a total enterprise value of approximately $8.5 billion, representing an acquisition multiple of 11.5x 2026E Adjusted EBITDA, including estimated annual run-rate cost synergies of $175 million by year three.
CRH is a serial dealmaker. The Dublin-based company moved its listing to New York, where it holds a market value of $74 billion, to benefit from higher valuations and significant building demand in the US. Peer stocks Martin Marietta Materials (NYSE: MLM) and Eagle Materials (NYSE: EXP) both attracted sector-wide attention on the news. This deal reshapes North American infrastructure materials leadership in one transaction.
The $8.5 Billion Deal: Structure and Premium
The offer structure is straightforward: all cash, no share consideration, and a meaningful premium that makes the strategic intent clear.
The offer to Arcosa stockholders implies a 25% premium to Arcosa’s 60-day trading volume-weighted average price as of June 18, 2026. The transaction is expected to be accretive to earnings, margin, and cash flow in the first 12 months post-completion.
Key deal terms confirmed on June 22, 2026:
- Offer price: $150 per share, all-cash
- Total enterprise value: $8.5 billion
- EBITDA multiple: 11.5x 2026E Adjusted EBITDA (including synergies)
- Premium to 60-day VWAP: 25% (as of June 18, 2026)
- Expected synergies: ~$175 million run-rate by year three
- Deal close deadline: June 21, 2027 (extendable by 6 months for regulatory approvals)
- Bridge financing arrangers: J.P. Morgan and Morgan Stanley
Synergies are expected to build to approximately $60 million in Year 1, $130 million in Year 2, and $175 million in Year 3, driven by production efficiencies, logistics, network optimization, self-supply opportunities, and global procurement savings.
Why Arcosa Fits CRH’s Strategy
This is not an opportunistic acquisition; it is a deliberate strategic build toward CRH’s 2030 financial targets.
Arcosa is headquartered in Dallas, Texas, and is a provider of infrastructure-related materials, products, and solutions. The acquisition strengthens CRH as the No. 1 infrastructure player in North America and reinforces CRH’s leadership in US aggregates, advancing its aggregates-led, connected portfolio strategy aligned with growing infrastructure megatrends.
The deal expands CRH’s aggregates platform to over 265 million metric tonnes of annualized production, with the transaction described as highly complementary to the existing business and backed by strong cultural alignment and a proven management team track record.
CRH Stock: What the Numbers Show on June 22
CRH entered this announcement from a position of operational and financial strength. Q1 2026 delivered clear evidence of that.
CRH (NYSE: CRH) key metrics on June 22, 2026:
- 52-week high: $131.55
- 52-week low: $76.75
- Market cap: $74 billion
- 1-month return: +8.87%
- 1-year return: +24.99%
- EBITDA (TTM): $7.56 billion (19.97% margin)
- Q1 2026 revenue: $7.37 billion (vs. $6.8 billion in Q1 2025)
- Next earnings date: August 20, 2026
CRH reaffirmed full-year 2026 guidance with expected net income of $3.9 billion to $4.1 billion and diluted EPS of $5.60 to $6.05.
Strategic Backdrop: CRH’s 2030 Ambitions
The Arcosa deal fits directly inside CRH’s clearly defined multi-year financial targets it is not M&A for its own sake.
CRH’s 2030 financial targets include 7% to 9% annual revenue growth, an Adjusted EBITDA margin of 22% to 24%, and greater than 100% Adjusted Free Cash Flow conversion, supported by approximately $40 billion in total financial capacity available through to 2030.
Earlier in 2026, CRH also acquired Axius Water in a $700 million deal, targeting expansion in US water infrastructure and aiming for approximately $200 million in net incremental EBITDA from acquisitions during the year. The Arcosa deal dwarfs that, but both move in the same strategic direction.
Conclusion
CRH’s $8.5 billion Arcosa acquisition, announced formally on June 22, 2026, is the clearest statement yet of where the company is heading. At $150 per share, with a 25% premium, $175 million in projected synergies, and a direct line to CRH’s 2030 targets, this deal is built on operational logic and financial discipline.
With a $74 billion market cap, $7.56 billion in EBITDA, and FY2026 EPS guidance of up to $6.05, CRH has the scale and balance sheet to absorb and integrate Arcosa without stretching its financial profile.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)